Experts in gynecologic oncology review key advances in treating advanced endometrial cancer and the promise of combination immunotherapy-based regimens.
EP. 1: Role of Combination I/O in Advanced Endometrial Cancer (EC)
EP. 2: Phase 3 KEYNOTE-775 Trial in Advanced Endometrial Cancer
EP. 3: Safety Results From KEYNOTE-775 Trial in Advanced EC
EP. 4: Impact of Lenvatinib-Pembrolizumab on Clinical Practice in Advanced EC
EP. 5: Patient Selection for Lenvatinib-Pembrolizumab for Advanced EC
EP. 6: Emerging Data From Ongoing IO Combination Trials in EC
EP. 7: Novel Combinations for the Treatment of Advanced EC
Sotigalimab/Pembrolizumab Combo Continues to Show Clinical Activity in Frontline Melanoma
Dr. Halmos on Trastuzumab Deruxtecan in NSCLC
Dr. Kris on Immunotherapy in NSCLC Without Driver Mutations
Checkpoint Inhibitor Challenges Warrant Consideration for a Targeted Approach in NSCLC
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.